Skip to content

Start Here
Research
Latest
Stock Market
Market Education
Capital Markets
Federal Reserve & Rates
About
Contact

adrx

ADARx Prices Upsized $446M Nasdaq IPO at $17 on siRNA Pipeline

September 26, 2026 by Bruno

AI-generated editorial image: Modern biotechnology laboratory cleanroom workbench with sterile glass vials and precision pipettes

ADARx Pharmaceuticals upsized its Nasdaq IPO to 26.25M shares at $17.00, raising $446.3M alongside an $89M AbbVie private placement.

Categories IPO & Public Offerings, Stock Market Tags adarx pharmaceuticals, adrx, biotech IPO, capital markets, sirna therapeutics

Search

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

Start Here
Market Education
Stock Market
Capital Markets
Federal Reserve & Rates

Recent Posts

Charles River Lifts 2026 Outlook and Targets 24% Margin by 2030
Capital Gains Tax on Stocks: Short-Term vs. Long-Term Rules
ADARx Prices Upsized $446M Nasdaq IPO at $17 on siRNA Pipeline
KLX Energy Services Lifts Q3 Guidance on Drilling Rebound
Treasury Floating Rate Notes: How Index Rates and Spreads Work

About · Editorial Policy · Corrections · Disclaimer · Privacy · Contact

© 2026 Equity Capital Market • Built with GeneratePress